Examples are Phortress, a synthetic CYP1A1 activated prodrug, currently undergoing phase-I trial, with potent activity against breast and colorectal cancer and resveratrol, a CYP1B1 activated cancer-preventative prodrug [32–34]. Here, CYP1A1 is linked to colorectal cancer.